A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

Updated on: February 01,2024

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

Updated on:February 01,2024

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins

Updated on: April 30,2024

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins

Updated on:April 30,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on: February 19,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on:February 19,2024

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on: May 09,2024

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on:May 09,2024

Softer tumors fuel more aggressive spread of triple-negative breast cancer, research shows

byGarvan Institute of Medical ResearchFluorescent image of cancer cells (cell nuclei in blue) stockpiling lipids in the form of lipid droplets (in red). The researchers showed these lipid drople

Updated on: April 28,2024

Softer tumors fuel more aggressive spread of triple-negative breast cancer, research shows

byGarvan Institute of Medical ResearchFluorescent image of cancer cells (cell nuclei in blue) stockpiling lipids in the form of lipid droplets (in red). The researchers showed these lipid drople

Updated on:April 28,2024

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on: June 28,2024

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on:June 28,2024

Discovery adds to evidence that some children are predisposed to develop leukemia

by St. Jude Children's Research HospitalCharles Mullighan, MBBS, M.D., Michelle Churchman Ph.D., Max Qian PhD, Jun Yang Ph.D. Credit: St. Jude Children's Research Hospital / Seth DixonSt.

Updated on: April 14,2024

Discovery adds to evidence that some children are predisposed to develop leukemia

by St. Jude Children's Research HospitalCharles Mullighan, MBBS, M.D., Michelle Churchman Ph.D., Max Qian PhD, Jun Yang Ph.D. Credit: St. Jude Children's Research Hospital / Seth DixonSt.

Updated on:April 14,2024

New cell model could help find treatments for one of the most common forms of childhood leukemia

byThe Spanish National Cancer Research CentreCredit: CC0 Public DomainB-cell acute lymphoblastic leukemia (B-ALL) is one of the most common forms of childhood cancer. The overall survival rate i

Updated on: January 12,2024

New cell model could help find treatments for one of the most common forms of childhood leukemia

byThe Spanish National Cancer Research CentreCredit: CC0 Public DomainB-cell acute lymphoblastic leukemia (B-ALL) is one of the most common forms of childhood cancer. The overall survival rate i

Updated on:January 12,2024

Study investigates link between oropharyngeal cancer and sexual behavior

byLeipzig UniversityVenn diagrams showing the distribution of self-reported high-risk sexual behavior (HR-SB) among N = 188 propensity-score-matched healthy adults and among N = 94 oropharyngeal

Updated on: January 22,2024

Study investigates link between oropharyngeal cancer and sexual behavior

byLeipzig UniversityVenn diagrams showing the distribution of self-reported high-risk sexual behavior (HR-SB) among N = 188 propensity-score-matched healthy adults and among N = 94 oropharyngeal

Updated on:January 22,2024

Tracing the footprints of a tumor—genomic 'scars' allow cancer profiling

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesHap1 Cells stained for different DNA damages (yellow = antibody against phosphorilated ATM; red = antibody against 53B

Updated on: April 01,2024

Tracing the footprints of a tumor—genomic 'scars' allow cancer profiling

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesHap1 Cells stained for different DNA damages (yellow = antibody against phosphorilated ATM; red = antibody against 53B

Updated on:April 01,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on: April 23,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on:April 23,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on: April 10,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on:April 10,2024